FDA Clears Camino Flex Ventricular Catheter For Use With MRI Scans

(RTTNews) - Integra LifeSciences Holdings Corp. (IART) said Friday that the Camino Flex Ventricular Catheter has received clearance from the United States Food and Drug Administration for use with magnetic resonance imaging.

The Camino Flex Ventricular Catheter is an advanced, tunneled ventricular catheter that is MR conditional at 1.5 and 3.0 T, with a sensor designed to measure directly at the source, and is used with Integra's next-generation Camino Monitor, which debuted in 2013.

Integra is a provider of advanced intracranial pressure monitoring systems. Over 800 centers in the United States use the Camino platform for conditions that cause an elevated intracranial pressure, including traumatic brain injury, subarachnoid hemorrhage, and stroke.

When coupled with the Camino Monitor, the Camino Flex Ventricular Catheter provides clinicians access to a truly advanced system for the diagnosis and treatment of compromised neurological conditions. Unlike other tunneled ventricular catheters that depend upon CSF flow to measure ICP, the Camino Flex Ventricular Catheter continuously monitors ICP independently in the ventricles, even when CSF flow cannot be established or the catheter is occluded by a blood clot. A multilumen design also allows for simultaneous CSF drainage and ICP monitoring, providing a continuous measurement of ICP and waveforms.